Successful therapy of crystalcryoglobulinemia: a case report.
Successful therapy for a case of multiple myeloma with a spontaneously crystallizing cryoglobulin of the IgG2-kappa light chain variety was achieved, using both continuous-flow cell centrifugation plasmapheresis to rapidly lower the M component and combination chemotherapy with phenylalanine mustard, prednisone, procarbazine, and vincristine to control the myeloma process. This resulted in resolution of incapacitating large and small necrotic cutaneous ulcerations of the extremities. Physicochemical studies of the crystalcryoprotein demonstrated that cryoprecipitation was rapid and accompanied by the formation of needle-shaped crystals, yet was completely reversible at 37 degrees C. Cryocrit determinations varied depending upon relative centrifugal forces and temperature and did not always relate linearly to the amount of abnormal protein, thus making these alone unreliable in assessing response to therapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003450:Cryoglobulins; D003460:Crystallization; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010956:Plasmapheresis
D000970:Antineoplastic Agents; D003450:Cryoglobulins; D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains